Overview
Beijing GoBroad Hospital is a research-oriented hospital in Beijing focused on the diagnosis and treatment of complex diseases, clinical research, and the translation of innovative biomedical technologies. As a flagship hospital of GoBroad Healthcare Group, it combines advanced clinical care with translational medicine and early-stage clinical research capabilities.
Located in Changping Life Science Park, Beijing, the hospital covers approximately 100,000 square meters and is designed with around 500 beds, including dedicated beds for early-phase clinical research. It officially opened in 2023 and focuses on innovative treatments for solid tumors, hematologic malignancies, and neurological diseases.
Focus on advanced cancer treatment
Beijing GoBroad Hospital specializes in cutting-edge oncology treatments, particularly:
- CAR-T cell therapy and other cellular immunotherapies
- Hematopoietic stem cell transplantation (HSCT)
- Precision diagnosis and targeted therapies
- Immunotherapy and clinical trials for advanced cancers
- Multidisciplinary treatment for complex and refractory diseases
The hospital has developed strong expertise in hematological cancers, including lymphoma, leukemia, and multiple myeloma, while also expanding research and treatment programs for solid tumors and emerging cellular therapies.
CAR-T cell therapy expertise
Beijing GoBroad Hospital is recognized as one of China’s leading centers for cellular immunotherapy. Its medical team has extensive experience in CAR-T therapy, covering the complete treatment pathway from patient evaluation and cell collection to manufacturing coordination, infusion, safety monitoring, and long-term follow-up.
The hospital provides CAR-T treatment options for eligible patients with diseases such as:
- B-cell lymphoma
- Acute lymphoblastic leukemia (ALL)
- Multiple myeloma
- Selected advanced cancers through clinical research programs
GoBroad Healthcare Group has established a comprehensive CAR-T clinical research and treatment platform and has accumulated experience in thousands of CAR-T procedures across its medical network.
Research-driven medical model
Unlike traditional hospitals that mainly focus on routine clinical care, Beijing GoBroad Hospital follows a research hospital model, integrating:
- Clinical treatment
- Early-phase clinical trials
- Precision diagnostics
- Biomedical innovation
- Data-driven medicine
The hospital works closely with research institutions, biotechnology companies, and medical innovators to accelerate the development and clinical application of new therapies.
Services for international patients
For international patients seeking advanced cancer treatment in China, Beijing GoBroad Hospital offers comprehensive medical support including:
- International medical consultation
- Medical record review and treatment evaluation
- Multidisciplinary expert consultation
- Advanced cancer treatment programs
- CAR-T and cell therapy access
- Clinical trial screening
- Long-term follow-up support
With its combination of clinical expertise, research capabilities, and experience in advanced cellular therapies, Beijing GoBroad Hospital is considered one of the important destinations in China for patients seeking innovative cancer treatments, especially CAR-T therapy and hematology oncology care.
